Moreover, a number of medications used to treat obesity act through dopaminergic receptors in the hypothalamus, providing a pharmacological basis for the connection between POMC and NPY neurons and the dopaminergic system30. Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.